Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated:  12/8/2015
Novartis Investigative Site
2483
mi
from 98109
Cambridge, MA
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated: 12/8/2015
Novartis Investigative Site
2483
mi
from 98109
Cambridge, MA
Click here to add this to my saved trials
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated:  12/8/2015
Novartis Investigative Site
2395
mi
from 98109
Teaneck, NJ
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated: 12/8/2015
Novartis Investigative Site
2395
mi
from 98109
Teaneck, NJ
Click here to add this to my saved trials
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated:  12/8/2015
Novartis Investigative Site
2289
mi
from 98109
Charlotte, NC
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated: 12/8/2015
Novartis Investigative Site
2289
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated:  12/8/2015
Novartis
146
mi
from 98109
Portland, OR
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated: 12/8/2015
Novartis
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated:  12/8/2015
Novartis Investigative Site
1667
mi
from 98109
Arlington, TX
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated: 12/8/2015
Novartis Investigative Site
1667
mi
from 98109
Arlington, TX
Click here to add this to my saved trials
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated:  12/8/2015
Novartis Investigative Site
1892
mi
from 98109
Houston, TX
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated: 12/8/2015
Novartis Investigative Site
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated:  12/8/2015
Novartis Investigative Site
6783
mi
from 98109
Sao Paulo,
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis
Status: Enrolling
Updated: 12/8/2015
Novartis Investigative Site
6783
mi
from 98109
Sao Paulo,
Click here to add this to my saved trials
Comparing the Effect of the Water Drinking Test on Intraocular Pressure
Comparing the Effect of the Water Drinking Test on Intraocular Pressure in Patients With Prior Trabeculectomy or Tube Shunt Surgeries
Status: Enrolling
Updated:  12/8/2015
Wills Eye Hospital
2373
mi
from 98109
Philadelphia, PA
Comparing the Effect of the Water Drinking Test on Intraocular Pressure
Comparing the Effect of the Water Drinking Test on Intraocular Pressure in Patients With Prior Trabeculectomy or Tube Shunt Surgeries
Status: Enrolling
Updated: 12/8/2015
Wills Eye Hospital
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/9/2015
Clinical Research Facility
1702
mi
from 98109
Racine, WI
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/9/2015
Clinical Research Facility
1702
mi
from 98109
Racine, WI
Click here to add this to my saved trials
Building a Database of Results From People Without Eye Problems
A Prospective Study of Controls to Build a Normative Database for the Spaeth/Richman Contrast Sensitivity Test (SPARCS)
Status: Enrolling
Updated:  12/9/2015
Wills Eye Glaucoma Service
2373
mi
from 98109
Philadelphia, PA
Building a Database of Results From People Without Eye Problems
A Prospective Study of Controls to Build a Normative Database for the Spaeth/Richman Contrast Sensitivity Test (SPARCS)
Status: Enrolling
Updated: 12/9/2015
Wills Eye Glaucoma Service
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Moxifloxacin vs. Polytrim for Conjunctivitis
A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.
Status: Enrolling
Updated:  12/11/2015
University of Rochester
2161
mi
from 98109
Rochester, NY
Moxifloxacin vs. Polytrim for Conjunctivitis
A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.
Status: Enrolling
Updated: 12/11/2015
University of Rochester
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
The Effects of Latanoprost, Bimatoprost and Travoprost on Periocular Skin Pigmentation
Status: Enrolling
Updated:  12/14/2015
Arlington Eye Physicians
1706
mi
from 98109
Arlington Heights, IL
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
The Effects of Latanoprost, Bimatoprost and Travoprost on Periocular Skin Pigmentation
Status: Enrolling
Updated: 12/14/2015
Arlington Eye Physicians
1706
mi
from 98109
Arlington Heights, IL
Click here to add this to my saved trials
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
The Effects of Latanoprost, Bimatoprost and Travoprost on Periocular Skin Pigmentation
Status: Enrolling
Updated:  12/14/2015
Summa Health System
2042
mi
from 98109
Akron, OH
The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
The Effects of Latanoprost, Bimatoprost and Travoprost on Periocular Skin Pigmentation
Status: Enrolling
Updated: 12/14/2015
Summa Health System
2042
mi
from 98109
Akron, OH
Click here to add this to my saved trials
Diabetic Macular Edema Treated With Ozurdex (DMEO)
Diabetic Macular Edema Treated With Ozurdex (DMEO)
Status: Enrolling
Updated:  12/15/2015
Wilmer Eye Institute
2328
mi
from 98109
Baltimore, MD
Diabetic Macular Edema Treated With Ozurdex (DMEO)
Diabetic Macular Edema Treated With Ozurdex (DMEO)
Status: Enrolling
Updated: 12/15/2015
Wilmer Eye Institute
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Propranolol for Diabetic Retinopathy
Propranolol for Diabetic Retinopathy
Status: Enrolling
Updated:  12/17/2015
University of Wisconsin-Madison
1616
mi
from 98109
Madison, WI
Propranolol for Diabetic Retinopathy
Propranolol for Diabetic Retinopathy
Status: Enrolling
Updated: 12/17/2015
University of Wisconsin-Madison
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Computer Vision System for the Blind Veteran
Computer Vision System for the Blind Veteran
Status: Enrolling
Updated:  12/18/2015
Atlanta VA Medical and Rehab Center, Decatur
2181
mi
from 98109
Decatur, GA
Computer Vision System for the Blind Veteran
Computer Vision System for the Blind Veteran
Status: Enrolling
Updated: 12/18/2015
Atlanta VA Medical and Rehab Center, Decatur
2181
mi
from 98109
Decatur, GA
Click here to add this to my saved trials
Computer Vision System for the Blind Veteran
Computer Vision System for the Blind Veteran
Status: Enrolling
Updated:  12/18/2015
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
2328
mi
from 98109
Baltimore, MD
Computer Vision System for the Blind Veteran
Computer Vision System for the Blind Veteran
Status: Enrolling
Updated: 12/18/2015
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
Comparative Study of Thymosin Beta 4 Eye Drops or Vehicle in the Treatment of Patients With Ocular Surface Defects Due to Severe Dry Eye
Status: Enrolling
Updated:  12/21/2015
Michigan Cornea Consultants, P.C.
1920
mi
from 98109
Southfield, MI
Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
Comparative Study of Thymosin Beta 4 Eye Drops or Vehicle in the Treatment of Patients With Ocular Surface Defects Due to Severe Dry Eye
Status: Enrolling
Updated: 12/21/2015
Michigan Cornea Consultants, P.C.
1920
mi
from 98109
Southfield, MI
Click here to add this to my saved trials
IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure
A Prospective, Explorative, Open Label Study to Assess the 24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Moderate to Severe Obstructive Sleep Apnea Syndrome Using Continuous Positive Airway Pressure With or Without Primary Open Angle Glaucoma
Status: Enrolling
Updated:  12/21/2015
The New York Eye and Ear Infirmary
2402
mi
from 98109
New-York, NY
IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure
A Prospective, Explorative, Open Label Study to Assess the 24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Moderate to Severe Obstructive Sleep Apnea Syndrome Using Continuous Positive Airway Pressure With or Without Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/21/2015
The New York Eye and Ear Infirmary
2402
mi
from 98109
New-York, NY
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
976
mi
from 98109
Artesia, CA
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
976
mi
from 98109
Artesia, CA
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2354
mi
from 98109
Newark, DE
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2354
mi
from 98109
Newark, DE
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2449
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2299
mi
from 98109
Augusta, GA
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2299
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
1794
mi
from 98109
Grand Rapids, MI
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
1794
mi
from 98109
Grand Rapids, MI
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2477
mi
from 98109
Portsmouth, NH
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2477
mi
from 98109
Portsmouth, NH
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2348
mi
from 98109
Slingerlands, NY
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2348
mi
from 98109
Slingerlands, NY
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2187
mi
from 98109
Asheville, NC
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2187
mi
from 98109
Asheville, NC
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2016
mi
from 98109
Lakewood, OH
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2016
mi
from 98109
Lakewood, OH
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2296
mi
from 98109
Kingston, PA
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2296
mi
from 98109
Kingston, PA
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2132
mi
from 98109
Pittsburgh, PA
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2132
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
2141
mi
from 98109
West Mifflin, PA
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
2141
mi
from 98109
West Mifflin, PA
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
1790
mi
from 98109
San Antonio, TX
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
1790
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated:  12/22/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 98109
Halifax,
Effect of Ruboxistaurin on Clinically Significant Macular Edema
The Effect of Ruboxistaurin on Vision Loss in Patients With Diabetes Mellitus and Clinically Significant Macular Edema
Status: Enrolling
Updated: 12/22/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 98109
Halifax,
Click here to add this to my saved trials
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
Phase 3, Multicenter,Parallel,Randomized Dbl-masked,Placebo-controlled Study of the Effects of 32 mg/dy Ruboxistaurin Vision Loss in Patients With Type 1 or Type 2 Diabetes Mellitus and an Early Treatment Diabetic Retinopathy Study Level Between 47A and 53E.
Status: Enrolling
Updated:  12/22/2015
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
Phase 3, Multicenter,Parallel,Randomized Dbl-masked,Placebo-controlled Study of the Effects of 32 mg/dy Ruboxistaurin Vision Loss in Patients With Type 1 or Type 2 Diabetes Mellitus and an Early Treatment Diabetic Retinopathy Study Level Between 47A and 53E.
Status: Enrolling
Updated: 12/22/2015
Clinical Research Facility
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
Retina Associates Southwest, PC
1219
mi
from 98109
Tucson, AZ
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
Retina Associates Southwest, PC
1219
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
Retina-Vitreous Associates Medical Group
959
mi
from 98109
Beverly Hills, CA
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
Retina-Vitreous Associates Medical Group
959
mi
from 98109
Beverly Hills, CA
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
Retinal Diagnostic Center
715
mi
from 98109
Campbell, CA
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
Retinal Diagnostic Center
715
mi
from 98109
Campbell, CA
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
Northern California Retina Vitreous Associates
707
mi
from 98109
Mountain View, CA
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
Northern California Retina Vitreous Associates
707
mi
from 98109
Mountain View, CA
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
Retina Research Institute of Texas
704
mi
from 98109
Palo Alto, CA
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
Retina Research Institute of Texas
704
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
William Beaumont Health System
1922
mi
from 98109
Royal Oak, MI
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
William Beaumont Health System
1922
mi
from 98109
Royal Oak, MI
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
New York Eye & Ear Infirmary
2401
mi
from 98109
New York, NY
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
New York Eye & Ear Infirmary
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
Retina Research Institute of Texas, LLC
1582
mi
from 98109
Abilene, TX
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
Retina Research Institute of Texas, LLC
1582
mi
from 98109
Abilene, TX
Click here to add this to my saved trials
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/23/2015
Retina Research Center
1769
mi
from 98109
Austin, TX
Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/23/2015
Retina Research Center
1769
mi
from 98109
Austin, TX
Click here to add this to my saved trials